Sun Pharma secures marketing rights for stroke drug Tyvalzi from Pharmazz
Sun Pharmaceutical Industries Limited has entered into a license agreement with U.S.-based biopharmaceutical company Pharmazz Inc. for the commercialization of the first-in-class innovative drug, Tyvalzi ... Read More
Zydus Hospitals, Medtronic launch AI-based stroke care network in Gujarat
Zydus Hospitals, Ahmedabad, and India Medtronic Private Limited, a fully-owned affiliate of American medical devices maker Medtronic announced a collaboration to help patients suffering from ... Read More
AstraZeneca gets BRILINTA FDA approval for reducing risk of stroke in acute ischemic stroke or high-risk transient ischemic attack
BRILINTA FDA approval : AstraZeneca has bagged approval for BRILINTA (ticagrelor) from the US Food and Drug Administration for its use in reducing the risk ... Read More
Seneca Biopharma completes cell manufacturing facility in Suzhou, China
Seneca Biopharma (formerly Neuralstem), a biopharma company engaged in developing treatments for diseases of high unmet medical need, has completed construction on its new cell ... Read More
CATALYST clinical trial : FDA approves Abbott’s trial of Amplatzer Amulet device in AF
Abbott has been granted approval from the US Food and Drug Administration (FDA) for the CATALYST clinical trial to assess its Amplatzer Amulet Left Atrial ... Read More
Lycopene Uses for Cardiovascular Diseases | Tomato Health Benefits
As per the research done by the scientists of Cambridge Theranostics Ltd, a biotech firm, lycopene pigment present in tomatoes protect us from cardiovascular diseases ... Read More